Advanced Serial Plasma Exchange Now Available in Miami as Environmental Toxin Concerns Rise Across South Florida
MIAMI, FL (March 30, 2026) — MDLifespan, a physician-led provider of Advanced Therapeutic Plasma Exchange, today announced the launch of its Advanced Serial Therapeutic Plasma Exchange (TPE) protocols inside Cenegenics Miami in Coral Gables.
The expansion brings MDLifespan’s structured, multi-session Advanced Therapeutic Plasma Exchange protocols to South Florida through a clinical integration with one of the country’s leading physician-led performance health centers.
Advanced Therapeutic Plasma Exchange Comes to Miami
The Miami launch comes as environmental research and public discussion continue to highlight concerns about environmental toxin exposure across South Florida.
Studies and regional reporting have identified environmental contaminants in Miami-area water systems, groundwater, and coastal ecosystems, including:
- PFAS (“forever chemicals”) detected in rainwater, groundwater, and drinking water
- Phthalates, plastics-related compounds found in local water and sediment
- Toxic metals and industrial pollutants associated with certain legacy sites, including Homestead Air Force Base
- Microplastics and chemical pollutants detected in aquatic environments including Biscayne Bay and the Miami River
Additional environmental concerns include harmful algal blooms, which can produce toxins in coastal waters, as well as wastewater-related contamination associated with aging infrastructure.
Because some environmental compounds can persist in the environment and may be present in the human body, they continue to be studied in relation to inflammation, immune function, and other aspects of human health.
As awareness grows, more individuals are seeking physician-led strategies to better understand environmental exposure and evaluate circulating toxin burden.
The Cenegenics Miami integration expands access to MDLifespan’s Advanced Serial Therapeutic Plasma Exchange protocols, which are designed to support the evaluation and reduction of circulating environmental toxin and inflammatory burden through physician-supervised care and biomarker analysis.
“South Florida presents a unique combination of environmental exposures—from waterborne pollutants to airborne toxins,” said Dr. Paul Savage, Founder and Chief Medical Officer of MDLifespan. “Our Advanced Serial Plasma Exchange protocols are structured, physician-supervised plans designed to support the reduction of circulating toxins while integrating with advanced biomarker analysis.”
What Advanced TPE Brings to the Miami Market
Through the Cenegenics Miami integration, patients now have access to:
- Multi-session, physician-led Advanced Serial Therapeutic Plasma Exchange protocols
- Targeted diagnostics focused on environmental toxin exposure
- Structured clinical pathways designed to support the reduction of systemic inflammatory burden
- Biomarker tracking to monitor changes over time
- Ongoing physician oversight throughout the protocol
Therapeutic Plasma Exchange is an established medical procedure that removes and replaces a portion of a patient’s plasma. It has historically been used in hospital and specialty-care settings for specific medical indications.
MDLifespan applies TPE within structured, multi-session protocols that incorporate diagnostic testing, biomarker evaluation, physician oversight, and individualized health strategies.
Each protocol begins with diagnostic testing designed to evaluate toxin burden and relevant biomarkers, followed by a series of supervised plasma exchange sessions. Progress can be evaluated through laboratory testing and physician review.
Integrating Precision Diagnostics with Advanced TPE
The collaboration reflects a broader physician-directed approach that combines:
- Precision biomarker analysis
- Environmental toxin assessment
- Multi-session plasma exchange protocols
- Ongoing physician oversight
Rather than positioning plasma exchange as a single intervention, MDLifespan delivers structured protocols designed to integrate into individualized health strategies and clinical monitoring.
This model allows physicians to evaluate environmental exposure and relevant biomarkers while considering Advanced Therapeutic Plasma Exchange as part of a broader, physician-supervised approach.
Supporting National Growth Through Strategic Clinical Partnerships
The Miami launch supports MDLifespan’s national expansion strategy, which centers on:
- Partnering with established physician-led clinics
- Integrating into existing performance-health infrastructures
- Delivering standardized, replicable Advanced Serial TPE protocols
- Expanding geographic access to physician-led toxin-burden evaluation and reduction protocols
The launch at Cenegenics Miami follows MDLifespan’s broader expansion into physician-led clinical environments across the United States.
As environmental exposure continues to receive attention across coastal and urban markets, MDLifespan continues to expand access to Advanced Therapeutic Plasma Exchange protocols designed to address circulating toxin burden within physician-supervised care.
Originally published via our press platform and republished in our official newsroom.
Jessica Rafaeil is a journalist and wellness writer specializing in therapeutic plasma exchange, sleep, nutrition, and alternative medicine. With over eight years of experience covering health trends, she has contributed to publications such as US Black Engineer and IT, Women of Color, Hispanic Engineer, Digital Journal, and Sway’s Universe. Jessica combines journalism with branding expertise to elevate the voices of health-focused brands while advocating for diversity and inclusion in media.